ISPO

Multidrug Resistance - MDR

Proteasome inhibition as a novel approach to cancer therapy

J Adams, PhD

The lambda-Int family recombinases, Cre and Flp are inhibited by topoisomerase I targeting anticancer drugs

RF Frøhlich, BSc, SG Hansen, BSc, FF Andersen, MSc, JR Olesen, MSc, M Jayaram, PhD, O Westergaard, PhD, BR Knudsen, Ph.D.,

Molecular basis of the ability of new antitumour agents - benzoperimidines and anthrapyridones - to overcome multidrug resistance.

Jolanta Tarasiuk, Barbara Stefanska, Katarzyna Tkaczyk-Gobis, Arlette Garnier-Suillerot, Edward Borowski

Genomic gain and loss associated with drug-resistance of CCRF-CEM leukemic cells

T Efferth, PhD, , I Verdorfer, PhD, A Sauerbrey, MD, H Miyachi, PhD, CR Chitambar, PhD, HG Drexler PhD, and E Gebhart, PhD

The cyclosporin PSC 833 prolongs survival of NOD-SCID mice following xenotransplantation with human myeloblasts carrying P-glycoprotein

G Lehne MD PhD , D Sørensen DVM MSc , GE Tjønnfjord MD PhD , C Beiske MD PhD , HE Rugstad MD PhD , T-A Hagve MD PhD , OPF Clausen MD PhD

DNA methyltransferase-3b is preferentially expressed in drug resistant cells

Rama S. Dwivedi, PhD; Y-Yong Qiu, MD, Bernard L. Mirkin, PhD, MD.

Evaluation of multidrug resistance in in vitro treated cells of cancerous patients versus healthy donors by single cell gel electrophoresis assay (SCGE) assay.

P. Poli , A. Buschini , C. Alessandrini , A. Martino , L. Pasini , V. Rizzoli , S. Bonomini , C. Rossi .

The activity of latent benzoperimidine esters to inhibit P-glycoprotein and MRP1 dependent efflux of pirarubicin from several lines of multidrug resistant tumour cells.

D. Glowacka-Rogacka, M. Arciemiuk, A. Kupiec, M.M. Bontemps-Gracz, E. Borowski, J. Tarasiuk

The effect of new antitumor agents on the energy metabolism of human erythrocytes.

Robert Nowak1, Irena Baranowska-Bosiacka1, Barbara Stefanska2, Alina Joanna Hlynczak1, Jolanta Tarasiuk1, 2